---
trial_id: 263
discovery_date: 2022-03-29 21:28:28.028211
date: 2022-03-29 21:28:28.028211
title: "A Scandinavian, randomized, rater-blinded study of single and double-dose (2x250 mcg e.o.d.) Betaferon in patients with early secondary progressive multiple sclerosis."
summary: |
  <p>EudraCT Number: 2005-001540-23<br />Sponsor Protocol Number: 309560<br />Sponsor Name: Schering Nordiska AB<br />Start Date: 2006-03-03<br />Medical condition: Early Secondary Progressive Multiple Sclerosis<br />Disease: <br />Population Age: Adults, Elderly<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001540-23/SE">SE</a> (Prematurely Ended), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001540-23/DK">DK</a> (Completed)</p>
link: 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2005-001540-23'
published_date: NaT
trial_source: Clinical Trials Register Europe
relevant: 
options:
  unlisted: false
---
<p>EudraCT Number: 2005-001540-23<br />Sponsor Protocol Number: 309560<br />Sponsor Name: Schering Nordiska AB<br />Start Date: 2006-03-03<br />Medical condition: Early Secondary Progressive Multiple Sclerosis<br />Disease: <br />Population Age: Adults, Elderly<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001540-23/SE">SE</a> (Prematurely Ended), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001540-23/DK">DK</a> (Completed)</p>